Jay W. Heinecke

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Alan Daugherty, J. Lawrence Dunn, Debra L. Rateri et al. · Journal of Clinical Investigation · 1994 · 1.3K citations · Full text

Life Sciences, Molecular Biology, Pathobiology +17

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Tomáš Vaisar, Subramaniam Pennathur, Pattie S. Green et al. · Journal of Clinical Investigation · 2007 · 940 citations · Full text

Life Sciences, Biochemistry, Cardiology +16

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Stanley L. Hazen, Jay W. Heinecke · Journal of Clinical Investigation · 1997 · 843 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes

Seigo Sugiyama, Yoshikatsu Okada, Galina K. Sukhova et al. · American Journal Of Pathology · 2001 · 699 citations

Life Sciences, Cardiology, Immunology +17

Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Maria B. Kadiiska, Beth C. Gladen, Donna D. Baird et al. · Free Radical Biology and Medicine · 2004 · 694 citations

Pharmacy, Biochemistry, Toxicology +17